Skip to product information
1 of 1

GeneBio Systems

SESN2 ELISA kit (Human)

SESN2 ELISA kit (Human)

SKU:SEC840Hu

Regular price £854.00 GBP
Regular price Sale price £854.00 GBP
Sale Sold out
Shipping calculated at checkout.

Size: 96Tests

# of Times Cited in literature: 7

Prepare Time: 1-3 days(please inquire for mutiple units)

Target Name: SESN2

Target Full Name: Sestrin 2

Alternative Names: HI95; SES2; SEST2

Target Species: Human

Uniprot: P58004

Gene ID: 83667

Featured Series: SE kit

Featured Series Function: Detects protein (regular version)

Specificity: Reactive with Human SESN2 / Sestrin 2

Method: Colormetric

Detection principle: Double-antibody Sandwich

Detection range: 0.156-10ng/mL

Sensitivity: 0.054ng/mL

Assay Time: 3h

Sample Size: 100uL

Recommended/Predicted Sample Types: Tissue Homogenates, Cell Lysates, Cell Culture Supernates and other Biological Fluids

Assay Precision: Intra-Assay: CV<10%, Inter-Assay: CV<12%

Reproducibility test menthod: Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Sestrin 2 (SESN2) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Sestrin 2 (SESN2) were tested on 3 different plates, 8 replicates in each plate. CV(%) = SD/meanX100

Storage: 4°C for 1 month/ -20°C for long-term(One year within shelf life)

Shelf-life: 12 months

Specificity: This assay has high sensitivity and excellent specificity for detection of Sestrin 2 (SESN2). No significant cross-reactivity or interference between Sestrin 2 (SESN2) and analogues was observed.

Stability: The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition. To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary: 1. Prepare all reagents, samples and standards; 2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C; 3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C; 4. Aspirate and wash 3 times; 5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C; 6. Aspirate and wash 5 times; 7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C; 8. Add 50µL Stop Solution. Read at 450nm immediately.

Test principle: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Sestrin 2 (SESN2). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Sestrin 2 (SESN2). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Sestrin 2 (SESN2), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Sestrin 2 (SESN2) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Research Area: Neuro science;

References Citing This Product: Sestrin-2 is significantly increased in malignant pleural effusions due to lung cancer and is potentially secreted by pleural mesothelial cells.

Plasma sestrin2 concentrations and carotid atherosclerosis

Correlation between sestrin2 expression and airway remodeling in COPD

Circulating Sestrin Levels Are Increased in Hypertension Patients

Sestrin2 Was Involved in Airway Remodeling in COPD: A Multi-level Research

Association between serum Sestrin2 level and diabetic peripheral neuropathy in type 2 diabetic patients

View full details